Antibiotic-free high-yield (-)-α-bisabolol production in Serratia marcescens via metabolic engineering and genomic integration of mevalonate pathway genes

as a chassis for terpenoid biosynthesis. It provides a novel strategy for the industrial production of high-value terpenoids.